PALUDAN CASPER,EDINGER JAMES,HARBACHEUSKI RHYOR,MURRAY ROSEANN,HARIRI ROBERT J.
申请号：
NZ61213206
公开号：
NZ612132A
申请日:
2006.10.13
申请国别(地区):
NZ
年份:
2015
代理人:
摘要：
Discloses the use of a placental stem cell population, wherein at least 80% of said placental cells in the population are CD10+, CD34-, CD105+ and CD200+ in the preparation of a medicament for suppressing an immune response associated with graft-versus-host disease.
